- Home
- PBYI vs NFE Comparison
PBYI vs NFE Comparison
Compare PBYI & NFE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBYI | NFE |
|---|---|---|
| Founded | 2010 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 364.9M | 324.4M |
| IPO Year | 2011 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PBYI | NFE |
|---|---|---|
| Price | $8.07 | $0.35 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $5.50 |
| AVG Volume (30 Days) | 374.7K | ★ 5.2M |
| Earning Date | 05-07-2026 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $27,685,000.00 | ★ $1,504,037,000.00 |
| Revenue This Year | N/A | $110.34 |
| Revenue Next Year | N/A | $3.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.03 | $0.32 |
| 52 Week High | $8.44 | $4.96 |
Technical Indicators
Market Signals| Indicator | PBYI | NFE |
|---|---|---|
| Relative Strength Index (RSI) | 56.00 | 35.46 |
| Support Level | $6.50 | $0.32 |
| Resistance Level | $8.42 | $0.41 |
| Average True Range (ATR) | 0.41 | 0.04 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 47.13 | 31.23 |
Price Performance
Historical ComparisonAbout PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also, it is developing Alisertib, a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis, resulting in apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About NFE New Fortress Energy Inc.
New Fortress Energy Inc is an integrated gas-to-power company. Its business model spans the entire production and delivery chain from natural gas procurement and liquefaction to logistics, shipping, terminals, and conversion or development of a natural gas-fired generation. It has invested in floating, liquefied natural gas vessels to lower the cost of acquiring gas while securing a long-term supply for its terminals. Its segments include Terminals & Infrastructure, and Ships. It generates the majority of its revenue from the Terminals & Infrastructure segment.